Page last updated: 2024-08-23

nigericin and Heart Diseases

nigericin has been researched along with Heart Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bao, P; Chen, R; Chen, X; Ge, J; Guan, L; Huang, Z; Li, M; Liang, Y; Su, Y; Xiao, Z; Yu, Y; Yu, Z1
Braumüller, S; Chakraborty, S; Gebhard, F; Huber-Lang, M; Kalbitz, M; Lackner, I; Weber, B1

Other Studies

2 other study(ies) available for nigericin and Heart Diseases

ArticleYear
Translocation of gasdermin D induced mitochondrial injury and mitophagy mediated quality control in lipopolysaccharide related cardiomyocyte injury.
    Clinical and translational medicine, 2022, Volume: 12, Issue:8

    Topics: Heart Diseases; Humans; Inflammation; Lipopolysaccharides; Mitochondria; Mitochondrial Permeability Transition Pore; Mitophagy; Myocytes, Cardiac; Nigericin; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Quality Control

2022
Toll-Like Receptor-Mediated Cardiac Injury during Experimental Sepsis.
    Mediators of inflammation, 2020, Volume: 2020

    Topics: Animals; Cell Line; Cytokines; Disease Models, Animal; Gap Junctions; Heart Diseases; Heart Injuries; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Nigericin; Oxidation-Reduction; Reactive Oxygen Species; Receptors, Purinergic P2X7; Sepsis; Signal Transduction; Tight Junction Proteins; Toll-Like Receptors; Troponin I

2020